Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Rectal Neoplasms 3 Colorectal Neoplasms 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Melanoma 2 Lymphoma, Mantle-Cell 2 Lymphoma 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uveal Melanoma 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Squamous Cell Carcinoma of Head and Neck 1 Solitary Fibrous Tumor, Pleural 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neurotoxicity Syndromes 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Malignant Tumor of Ill-defined Site 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1

Interventions

Temozolomide 154 Bevacizumab 88 Radiotherapy 75 Radiation 23 Magnetic Resonance Spectroscopy 23 Lomustine 18 Irinotecan 18 pembrolizumab 17 Surgical Procedures, Operative 16 Carmustine 16 Erlotinib Hydrochloride 12 Nivolumab 11 Specimen Handling 10 Aminolevulinic Acid 10 sargramostim 9 Thalidomide 9 Chemotherapy, Adjuvant 9 Carboplatin 9 Drug Therapy 8 Immunoglobulin G 7 Filgrastim 7 Etoposide 7 Disulfides 7 Cilengitide 7 Sunitinib 6 Sorafenib 6 O(6)-benzylguanine 6 Cyclophosphamide 6 antineoplaston AS 2-1 5 antineoplaston A10 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Glioblastoma × Pharmacogenomic Testing × Clear all

NCT03216499 2022-05-09

PT2385

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed

24 enrolled 11 charts

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡